Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation emai
Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
The absence of a specific T-cell subset may help explain why three in four patients with advanced chronic lymphocytic leukemia (CLL) fail to respond to Kymriah (tisagenlecleucel) — a CAR T-cell therapy approved for another kind of leukemia, according to researchers. ... Read more